News

Zenotech Laboratories Limited will hold a board meeting on Wednesday, October 28, 2026, to consider and approve the unaudited standalone financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Limited. The trading window for the company`s shares has been closed since Thursday, October 1, 2026, and will remain closed until Friday, October 30, 2026, following the announcement of the financial results.

Zenotech Laboratories Limited submitted a compliance certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as confirmed by KFin Technologies Limited, its Registrar & Share Transfer Agent, on October 8, 2026.

Zenotech Laboratories Limited will close its trading window for share transactions starting Thursday, October 1, 2026, and continuing for 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026, as per the company’s code of conduct for prohibition of insider trading.

Zenotech Laboratories announced that the 37th Annual General Meeting(AGM) of the company will be held on 25 September 2026.

Net loss of Zenotech Laboratories reported to Rs 0.46 crore in the quarter ended June 2026 as against net profit of Rs 0.99 crore during the previous quarter ended June 2025. Sales rose 11.11% to Rs 9.60 crore in the quarter ended June 2026 as against Rs 8.64 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales9.608.64 11 OPM %8.8528.47 - PBDT1.293.05 -58 PBT-0.611.28 PL NP-0.460.99 PL Powered by Capital Market - Live News